PHLT 8072 Week 10 Melioidosis Emerging Threat Brief Example

Course	PHLT 8072 Communicable Disease Epidemiology
Week	Week 10
Paper type	Emerging threat brief
Length	About 540 words, 4 pages
Format	APA 7 student paper
School	Walden University
Program	PhD in Public Health
Updated	October 2026

Free sample paper for PHLT 8072 Week 10

A Tropical Soil Bacterium on the Gulf Coast: An Emerging Threat Brief on Melioidosis and the Three Assumptions It Breaks for a Composite County's Laboratories and Clinicians

Student Name

Walden University

PHLT 8072: Communicable Disease Epidemiology

Instructor Name

Month Day, Year

What this page is doingThe title names the organism's new setting and the brief's organizing idea, broken assumptions, so readers know the document is about what must change in practice.

A Tropical Soil Bacterium on the Gulf Coast: An Emerging Threat Brief on Melioidosis and the Three Assumptions It Breaks for a Composite County's Laboratories and Clinicians

Why This Brief Now

Melioidosis, caused by Burkholderia pseudomallei, has long been treated in the United States as a disease of travelers returning from Southeast Asia or northern Australia. That assumption no longer holds. Investigators linked three patients in one Mississippi Gulf Coast county, ill over three years, to the same strain of the bacterium found in soil and water samples from one patient's property, showing that the organism had become established in the local environment (Petras et al., 2023). This brief is written for a composite neighboring county with similar soils, rainfall and warm temperatures. Its purpose is to show how melioidosis strains three assumptions that local practice depends on and what each failure requires.

What this page is doingOpening with the documented local acquisition establishes that the threat is current, not speculative.

Assumption 1: Standard Laboratory Methods Will Identify the Organism

Most hospital laboratories rely on automated identification systems that work well for common pathogens. B. pseudomallei is rarely seen in temperate laboratories and can be misidentified by such systems as a less dangerous relative or dismissed as a contaminant. Culture of appropriate clinical material remains the mainstay of diagnosis, and identification is best done by phenotypic methods, while serology has only a limited role (Gassiep et al., 2020). Misidentification delays correct treatment and exposes laboratory staff, since the organism is a tier 1 select agent.

What Must Change

Laboratories should know the organism's culture features and refer suspicious isolates to the state public health laboratory. Clinicians should tell the laboratory when melioidosis is suspected.

Assumption 2: No Travel History Means No Melioidosis

Clinicians often consider melioidosis only after asking about travel. Local acquisition removes that filter. Infection follows contact with contaminated soil or water through skin wounds, inhalation or ingestion, and risk rises with heavy rainfall and storms (Gassiep et al., 2020). Diabetes, heavy alcohol use and immunosuppression increase the risk of disease (Wiersinga et al., 2018).

What Must Change

Clinicians in the county should consider melioidosis in patients with pneumonia, sepsis or abscesses who have these risk factors and soil or water exposure, especially after storms, regardless of travel.

Assumption 3: An Infection Ends When the Patient Recovers

Melioidosis can remain latent for long periods before causing illness, and it can relapse after apparently successful treatment. Its presentations range from acute pneumonia with bacteremia to abscesses in internal organs (Gassiep et al., 2020). Treatment requires a prolonged course with specific antibiotics, and inadequate treatment invites relapse (Wiersinga et al., 2018).

What Must Change

Cases need follow-up beyond the acute illness, and surveillance should record relapses as well as new cases.

Why It Counts as Emerging

The organism is not new, but its recognized range is growing. Modeling has predicted that environmental suitability for B. pseudomallei extends well beyond the regions where melioidosis is commonly reported, and that the disease is substantially underreported worldwide (Limmathurotsakul et al., 2016). The Gulf Coast finding fits that prediction.

Recommendations for the County

Notify hospital laboratories and clinicians of the regional finding and the organism's laboratory features. Ensure suspected isolates go to the state laboratory. Add melioidosis to clinician education after major storms. Work with the state to consider environmental sampling in high-risk areas.

References

Gassiep, I., Armstrong, M., & Norton, R. (2020). Human melioidosis. Clinical Microbiology Reviews, 33(2), e00006-19. https://doi.org/10.1128/CMR.00006-19

Limmathurotsakul, D., Golding, N., Dance, D. A. B., Messina, J. P., Pigott, D. M., Moyes, C. L., Rolim, D. B., Bertherat, E., Day, N. P. J., Peacock, S. J., & Hay, S. I. (2016). Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiology, 1, 15008. https://doi.org/10.1038/nmicrobiol.2015.8

Petras, J. K., Elrod, M. G., Ty, M. C., Dawson, P., O'Laughlin, K., Gee, J. E., Hanson, J., Boutwell, C., Ainsworth, G., Beesley, C. A., Saile, E., Tiller, R., Gulvik, C. A., Ware, D., Sokol, T., Balsamo, G., Taylor, K., Salzer, J. S., Bower, W. A., . . . Byers, P. (2023). Locally acquired melioidosis linked to environment, Mississippi, 2020-2023. The New England Journal of Medicine, 389(25), 2355-2362. https://doi.org/10.1056/NEJMoa2306448

Wiersinga, W. J., Virk, H. S., Torres, A. G., Currie, B. J., Peacock, S. J., Dance, D. A. B., & Limmathurotsakul, D. (2018). Melioidosis. Nature Reviews Disease Primers, 4, 17107. https://doi.org/10.1038/nrdp.2017.107

The Walden PHLT 8072 Week 10 instructions

The tenth week generally asks for a brief on an emerging or reemerging infectious disease threat relevant to a specific setting. Faculty expect the brief to explain why the threat is emerging, citing recent evidence, and to identify what in current practice it challenges, from laboratory methods to clinical suspicion to surveillance. Recommendations should be concrete and aimed at the people who would act on them. Briefs usually run two to three pages, written for a professional audience such as clinicians, laboratory directors or health officers, and draw on current peer-reviewed sources. Students should avoid sensationalism, stating clearly what is known and what remains uncertain, and should explain the emergence concept they are using.

How this PHLT 8072 Week 10 example is built

The brief opens with the Mississippi investigation that established local acquisition and states its purpose for a neighboring composite county. Three sections each take one assumption, explain why melioidosis breaks it and end with what must change. The laboratory section cites a clinical review on culture, phenotypic identification and the limited role of serology, and notes the organism's select agent status. The travel section describes routes of infection, the link to heavy rain and risk factors, citing two reviews. The recovery section covers latency, relapse and the need for prolonged treatment. A section explains why the disease counts as emerging, citing modeling of its predicted global range. Recommendations for laboratories, clinicians and environmental sampling close the brief.

Reading the PHLT 8072 Week 10 rubric

Instructors grade an emerging threat brief on currency, insight and actionability. Citing the recent documentation of local acquisition earns credit for currency and establishes why the brief matters now. Insight comes from identifying specific assumptions the pathogen breaks, which the sample organizes as its structure, rather than summarizing the disease. Actionability is shown by pairing each broken assumption with a change and ending with recommendations for named audiences. Accuracy is checked in claims about laboratory identification, risk factors and relapse, all supported by reviews. A measured tone that avoids alarm while stating real risks is rewarded. Clear headings, concise writing and correct references complete the criteria for this brief.

Common PHLT 8072 Week 10 mistakes, and how to avoid them

Emerging threat briefs often read as disease summaries, covering history, symptoms and treatment without saying what should change locally. Organize around the problem the threat creates for practice. Another common weakness is relying on older sources; for an emerging threat, the most recent evidence is the reason the brief exists. Students also overstate risk, which undermines credibility, or understate it by burying the key finding. State what is known plainly. Make recommendations specific: who should do what, and when. For laboratory-relevant threats, remember biosafety. Finally, explain what makes the threat emerging rather than assuming the label speaks for itself. A free custom brief can be written on the emerging threat your prompt assigns.

Get a PHLT 8072 Week 10 example written to your instructions

Name the emerging agent your section is examining; the Week 10 prompt and rubric complete the request. The brief identifies the assumptions in existing guidance that the agent breaks, explains the feature responsible for each, and summarizes the resulting changes in one table. Your first brief is free; 24-48 hours.

More PHLT 8072 papers and PhD in Public Health samples

PHLT 8072 Week 10 questions, answered

Where can I find a free PHLT 8072 Week 10 sample paper?

The whole Week 10 emerging threat brief appears on this page, explaining how melioidosis on the Gulf Coast breaks three assumptions in laboratory and clinical practice, with recommendations for a composite county. The references are real.

Why is melioidosis now considered an emerging threat in the United States?

Investigators linked three Mississippi patients over three years to Burkholderia pseudomallei found in local soil and water, showing the organism had become established in the continental United States rather than appearing only in travelers.

Why can laboratories miss Burkholderia pseudomallei?

It is rarely seen in temperate hospital laboratories, and automated identification systems can misidentify it or it can be dismissed as a contaminant. Culture with phenotypic identification remains the mainstay, and suspicious isolates should go to a public health laboratory.

Who is at higher risk of melioidosis?

Risk factors for disease include diabetes, heavy alcohol use and immunosuppression. Infection follows contact with contaminated soil or water through wounds, inhalation or ingestion, and cases rise after heavy rain and storms.

Can melioidosis come back after treatment?

Yes. The infection can remain latent for long periods and can relapse after apparently successful treatment, especially if the antibiotic course is too short. That is why the brief recommends follow-up beyond the acute illness and surveillance that records relapses.